Screened Selection Design for Randomised Phase II Oncology Trials: An Example in Chronic Lymphocytic Leukaemia

Trials - United Kingdom
doi 10.1186/1745-6215-12-s1-a91
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC